Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine.

AAA currently has over 1,000 employees working across 29 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US).  The company also has global manufacturing capabilities with 19 facilities in eight countries.

For more information, please visit: https://www.adacap.com/

More Information:

• • To learn more about our focus visit:  www.adacap.com/our-focus/prostate-cancer/

  • To learn more about PSMA visit: www.scanforpsma.com

  • Advanced Accelerator Application’s patient support line: 1-844-638-7222  M-F 8 AM – 8 PM ET

  • For more information on AAA Patient Connect download the brochure

Other Downloadable Information:

• • PSMA: What it is, why it matters

  • Taking on advanced prostate cancer takes teamwork: Meet your health care team

  • Nuclear Medicine and Your Health

  • Start the conversation: A guide for talking about advanced prostate cancer

Contact Person:

patientadvocacy.aaa@novartis.com